KINS is a research company that offers expertise in research into bacteria to run clinics and develop new drugs.
KINS has raised $3.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
KINS's investors include Panasonic, Shizuoka Capital, Rakuten, Nippon Express, Suzuyo.
KINS is headquartered in Ginza, Japan.
KINS is a research company that offers expertise in research into bacteria to run clinics and develop new drugs.
KINS is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KINS — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/kins. Accessed July 20, 2026.
VCBacked. (2024). KINS — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/kins
{{cite web |title=KINS — Funding & Investors |url=https://www.vcbacked.co/company/kins |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated